Sumant Ramachandra's most recent trade in Lyell Immunopharma Inc was a trade of 130,000 Option (right to buy) done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyell Immunopharma Inc | Sumant Ramachandra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Sumant Ramachandra | Director | Purchase of securities on an exchange or from another person at price $ 0.58 per share. | 21 Mar 2025 | 200,000 | 200,000 | - | 0.6 | 115,220 | Common Stock |
| Lyell Immunopharma Inc | Sumant Ramachandra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 260,000 | 260,000 | - | - | Option (right to buy) |